NCT07078500
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,264 public trials
216 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT07126236
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Hospital Universitario Miguel Servet Zaragoza, Aragon, Spain
- Hospital Universitario de Burgos Burgos, Castille and León, Spain
- ICO Badalona Badalona, Catalonia, Spain
- Hospital Universitari Vall d'Hebrón Barcelona, Catalonia, Spain
NCT07124936
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- The Affiliated Tumor Hospital of Guangxi Medical University Nanning, Guangxi, China
Recruiting
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
NCT06375733
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Guangxi Medical University Cancer Hospital&Guangxi Cancer Institute Nanning, China
- Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital Zhengzhou, China
NCT02393157
- Conditions
- Burkitt Lymphoma, CD20+ Lymphoblastic Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- New York Medical College Valhalla, New York, United States
NCT06213636
- Conditions
- Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, in Relapse, Central Nervous System Lymphoma, +19 more
- Locations
-
- District One Hospital Beijing, Beijing Municipality, China
Recruiting
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
NCT06045910
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom
- Cambridge University Hospitals Cambridge, United Kingdom
- St James's University Hospital Leeds, United Kingdom
- University Hospital London Hospital London, United Kingdom
NCT06651853
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
NCT07072208
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07070648
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China